Back

Olanzapine  Orally Dispersible Tablets

5 & 10 mg

central nervous system

details

Olanzapine is indicated for treating schizophrenia and symptoms of psychotic disorders.
Unipharm’s generic Olanzapine Orally Dispersible Tablets have been manufactured and marketed in Israel since 2013.

  • ATC4: N05AH
  • Strengths: 5 & 10 mg
  • Dosage forms: Orally Dispersible Tablets (ODT) & Tablets
  • Out-licensing is offered for all international markets*
  • Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products

Amisulpride
Tablets

100 & 400 mg
Fluphenazine Decanoate
Solution for Injection

25 mg/ml (1 ml)
Haloperidol Decanoate
Solution for Injection

100 mg/ml (1 ml)
Olanzapine
Tablets

5, 7.5 & 10 mg